Building on a prior study, we propose a hypothesis that ALYREF may interact with the 5-methylcytosine modification on ACC1 mRNA and trigger the proliferation and lipid synthesis of PCa cells through activating the CDK13/NSUN5/ACC1 pathway (Zhang Y. et al., 2023). The gene discussed is NSUN5; the disease is posterior cortical atrophy.